Production / Operations

FendX Engages Galenvs for Pilot Scale-Up Manufacturing of Its Liquid Surface Coating

FendX Pivots Manufacturing Strategy Amidst Partnership Exit

By The Northwire Desk — AI Analysis Apr 15, 2026 · 07:01 FNDX · 0.44 FendX Technologies Inc.

Executive Summary

FendX Technologies Inc. entered a Statement of Work (SOW) with Galenvs Sciences Inc. for pilot-scale manufacturing of its liquid surface coating.
The project involves producing three independent lots to evaluate antimicrobial performance, consistency, and manufacturability.
Simultaneously, the company terminated its Collaboration Agreement and Memorandum of Understanding with Aquaox LLC.
Reason for termination: The initial technical feasibility phase was deemed not feasible by FendX management.
A provisional patent was filed on October 21, 2025, for the liquid surface coating technology.
Management states this pilot is an important step toward commercialization with a potentially streamlined pathway to scale-up at low cost of manufacturing.

Material Impact

The news represents incremental progress on the flagship liquid surface coating product rather than a fundamental shift in business model or revenue generation.
Termination of the Aquaox agreement removes potential external validation and partnership upside, signaling execution risk in that specific collaboration avenue.
Engaging Galenvs confirms management is proceeding with internal manufacturing scale-up plans previously outlined in the March 31 corporate update.
The debt settlement announced earlier (April 10) reduced liabilities but increased share count, indicating continued reliance on equity dilution to manage cash flow.
Given the stock price decline from $1.00 in January to $0.37 in March, this news acts as a stabilization measure rather than a catalyst for significant re-rating without revenue proof.

FNDX · Price

Company Overview

FendX Technologies Inc. focuses on antimicrobial technologies for healthcare, consumer, and commercial markets.
Flagship Project: Liquid Surface Coating designed to provide sustained antimicrobial protection on high-touch surfaces using nanoparticle technology.
Secondary Projects: Foley catheter coating program and an AI-driven surface contamination detection app (both have provisional patents filed).
Development Stage: Pre-revenue; currently in pilot manufacturing and patent filing stages.
Previous Product Line: REPELWRAP film development was discontinued to focus on the liquid formulation.

More from FendX Technologies Inc.